Moreover, a recent study in melanoma patients revealed that anti-CTLA-4 induces a robust clonal expansion of progenitor exhausted T cells which, in turn, promotes exhausted T cell reinvigoration when combined with anti-PD-1 treatment (99). The gene discussed is CTLA4; the disease is melanoma.